Just out @NEJM from @DhruvKhullar et al. The structure of rewards (and costs) in pharmaceutical drug development. We introduce the 'reward box' interactive graphic to see how the elements interplay, how specific policies affect it.https://www.nejm.org/doi/full/10.1056/NEJMhpr1911004?query=featured_home …
-
-
And here is a sample of 3 policies we describe and how they alter the Reward Box shape and thus the risk and reward of developing particular types of drugs:pic.twitter.com/lJd213pOVo
Prikaži ovu nit -
Graphic labeled the 'Reward Box' to enable the double entendre sub-header in the title. But also, we want policymakers to in fact 'think inside the box'. The market is a policy construct, it is not 'free'. The industry sees it all of a piece, policy makers should too.
Prikaži ovu nit
Kraj razgovora
Novi razgovor -
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.